CAR-T cell therapy is a form of immunotherapy that uses modified T cells to recognize and destroy cancer cells. By modifying a patient's T cells to carry a specific receptor (CAR), they are able to identify and attack cancer cells.

CAR-T cell therapy is applicable to various hematologic malignancies, such as leukemia, lymphoma, and multiple myeloma. This includes B-cell Acute Lymphoblastic Leukemia(B-ALL), T-cell Acute Lymphoblastic Leukemia (T-ALL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and other related conditions.

Our hospital boasts a world-class medical team and advanced therapeutic technologies. Our expert team, composed of hematologists, diagnosticians, and immunologists, is dedicated to providing patients with the most suitable care and therapeutic outcomes.

Our medical team will evaluate whether you are a suitable candidate for CAR-T cell therapy based on your medical history and physical condition. If yes, we will provide you with a personalized treatment plan and work together with you to determine the most suitable treatment path.

During the treatment, you will need to follow the recommendations of the medical team and attend all scheduled treatments and follow-up appointments. Our nursing staff will assist you throughout the process, providing necessary support and care.

After treatment, we offer regular follow-up services to monitor your condition and the effectiveness of the treatment. Our medical team will adjust your treatment plan as needed and provide ongoing support and care.